BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23958451)

  • 1. Three Ca2+ channel inhibitors in combination limit chronic secondary degeneration following neurotrauma.
    Savigni DL; O'Hare Doig RL; Szymanski CR; Bartlett CA; Lozić I; Smith NM; Fitzgerald M
    Neuropharmacology; 2013 Dec; 75():380-90. PubMed ID: 23958451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific ion channels contribute to key elements of pathology during secondary degeneration following neurotrauma.
    O'Hare Doig RL; Chiha W; Giacci MK; Yates NJ; Bartlett CA; Smith NM; Hodgetts SI; Harvey AR; Fitzgerald M
    BMC Neurosci; 2017 Aug; 18(1):62. PubMed ID: 28806920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of ion channel inhibitor combinations for limiting secondary degeneration following partial optic nerve transection.
    Toomey LM; Bartlett CA; Majimbi M; Gopalasingam G; Rodger J; Fitzgerald M
    Exp Brain Res; 2019 Jan; 237(1):161-171. PubMed ID: 30367192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary degeneration of the optic nerve following partial transection: the benefits of lomerizine.
    Fitzgerald M; Bartlett CA; Evill L; Rodger J; Harvey AR; Dunlop SA
    Exp Neurol; 2009 Mar; 216(1):219-30. PubMed ID: 19118550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited restoration of visual function after partial optic nerve injury; a time course study using the calcium channel blocker lomerizine.
    Selt M; Bartlett CA; Harvey AR; Dunlop SA; Fitzgerald M
    Brain Res Bull; 2010 Mar; 81(4-5):467-71. PubMed ID: 19913075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing modes of delivery of a combination of ion channel inhibitors for limiting secondary degeneration following partial optic nerve transection.
    Toomey LM; Bartlett CA; Gavriel N; McGonigle T; Majimbi M; Gopalasingam G; Rodger J; Fitzgerald M
    Sci Rep; 2019 Oct; 9(1):15297. PubMed ID: 31653948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new calcium channel antagonist, lomerizine, alleviates secondary retinal ganglion cell death after optic nerve injury in the rat.
    Karim Z; Sawada A; Kawakami H; Yamamoto T; Taniguchi T
    Curr Eye Res; 2006 Mar; 31(3):273-83. PubMed ID: 16531285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myelin sheath decompaction, axon swelling, and functional loss during chronic secondary degeneration in rat optic nerve.
    Payne SC; Bartlett CA; Harvey AR; Dunlop SA; Fitzgerald M
    Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6093-101. PubMed ID: 22879411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific combinations of ion channel inhibitors reduce excessive Ca
    O'Hare Doig RL; Bartlett CA; Smith NM; Hodgetts SI; Dunlop SA; Hool L; Fitzgerald M
    Neuroscience; 2016 Dec; 339():450-462. PubMed ID: 27725216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Near infrared light reduces oxidative stress and preserves function in CNS tissue vulnerable to secondary degeneration following partial transection of the optic nerve.
    Fitzgerald M; Bartlett CA; Payne SC; Hart NS; Rodger J; Harvey AR; Dunlop SA
    J Neurotrauma; 2010 Nov; 27(11):2107-19. PubMed ID: 20822460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic swelling and abnormal myelination during secondary degeneration after partial injury to a central nervous system tract.
    Payne SC; Bartlett CA; Harvey AR; Dunlop SA; Fitzgerald M
    J Neurotrauma; 2011 Jun; 28(6):1077-88. PubMed ID: 21381867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early events of secondary degeneration after partial optic nerve transection: an immunohistochemical study.
    Fitzgerald M; Bartlett CA; Harvey AR; Dunlop SA
    J Neurotrauma; 2010 Feb; 27(2):439-52. PubMed ID: 19852581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel combinations of ion channel inhibitors for treatment of neurotrauma.
    O'Hare Doig RL; Fitzgerald M
    Discov Med; 2015 Jan; 19(102):41-7. PubMed ID: 25636960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary retinal ganglion cell death and the neuroprotective effects of the calcium channel blocker lomerizine.
    Fitzgerald M; Payne SC; Bartlett CA; Evill L; Harvey AR; Dunlop SA
    Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5456-62. PubMed ID: 19474405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha2-adrenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration.
    Yoles E; Wheeler LA; Schwartz M
    Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):65-73. PubMed ID: 9888428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Lycium barbarum (Wolfberry) on alleviating axonal degeneration after partial optic nerve transection.
    Li HY; Ruan YW; Kau PW; Chiu K; Chang RC; Chan HH; So KF
    Cell Transplant; 2015; 24(3):403-17. PubMed ID: 25622224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paranode Abnormalities and Oxidative Stress in Optic Nerve Vulnerable to Secondary Degeneration: Modulation by 670 nm Light Treatment.
    Szymanski CR; Chiha W; Morellini N; Cummins N; Bartlett CA; O'Hare Doig RL; Savigni DL; Payne SC; Harvey AR; Dunlop SA; Fitzgerald M
    PLoS One; 2013; 8(6):e66448. PubMed ID: 23840470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A model to study differences between primary and secondary degeneration of retinal ganglion cells in rats by partial optic nerve transection.
    Levkovitch-Verbin H; Quigley HA; Martin KR; Zack DJ; Pease ME; Valenta DF
    Invest Ophthalmol Vis Sci; 2003 Aug; 44(8):3388-93. PubMed ID: 12882786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The raft-associated protein MAL is required for maintenance of proper axon--glia interactions in the central nervous system.
    Schaeren-Wiemers N; Bonnet A; Erb M; Erne B; Bartsch U; Kern F; Mantei N; Sherman D; Suter U
    J Cell Biol; 2004 Aug; 166(5):731-42. PubMed ID: 15337780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optic nerve transection in monkeys may result in secondary degeneration of retinal ganglion cells.
    Levkovitch-Verbin H; Quigley HA; Kerrigan-Baumrind LA; D'Anna SA; Kerrigan D; Pease ME
    Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):975-82. PubMed ID: 11274074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.